Kinesin-1 controls mast cell degranulation and anaphylaxis through PI3K-dependent recruitment to the granular Slp3/Rab27b complex
Gaël Ménasché(Inserm), Luca Danelli(Inserm), Alain Fischer(Inserm), Geneviève de Saint Basile(Inserm), Nicolas Goudin(Délégation Paris 5), Ulrich Blank(Centre National de la Recherche Scientifique), Iris K. Madera‐Salcedo(Inserm), Claudia González‐Espinosa(Centro de Investigación en Materiales Avanzados), Mathieu Kurowska(Délégation Paris 5), Julien Claver(Inserm), Jian‐Dong Huang(Sun Yat-sen University)
Cited by 46
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k